Mwipatayi Patrice B, Suthers Elizabeth, Thomas Shannon D, Altaf Nishath
Department of Vascular Surgery, Royal Perth Hospital, Perth, Australia -
J Cardiovasc Surg (Torino). 2016 Jun;57(3):336-42. Epub 2016 Mar 31.
The last two decades have seen a revolution in the treatment of aortoiliac occlusive disease (AIOD). Acceptable safety and durability outcomes have now been realized with endovascular treatments, which is increasingly finding a place in the treatment of AIOD. Evolution of stent technologies and endovascular techniques is seeing an expansion of AIOD lesions indicated for primary endovascular treatment. The literature evidence basis is continuously evolving, and questions remain as to the optimal form of vessel treatment. Covered stents have been increasingly promoted for their long-term durability, particularly in extensive, challenging AIOD lesions. Here, we explore the seminal evidence basis for covered stents in the treatment of AIOD, and aim to provide a sound evidence based argument for their use.
在过去二十年中,主髂动脉闭塞性疾病(AIOD)的治疗发生了一场变革。血管内治疗现已实现了可接受的安全性和耐久性结果,并且在AIOD治疗中越来越占据一席之地。支架技术和血管内技术的发展使得适合进行原发性血管内治疗的AIOD病变范围不断扩大。文献证据基础在持续演变,关于血管治疗的最佳形式仍存在疑问。覆膜支架因其长期耐久性而越来越受到推崇,尤其是在广泛、具有挑战性的AIOD病变中。在此,我们探讨覆膜支架治疗AIOD的关键证据基础,旨在为其应用提供有力的循证依据。